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UDPgalactose 4-epimerase (epimerase) catalyzes the
reversible conversion between UDPgalactose and UDPglu-
cose and is an important enzyme of the galactose metabolic
pathway. The Saccharomyces cerevisiae epimerase encoded
by the GAL10 gene is about twice the size of either the
bacterial or human protein. Sequence analysis indicates that
the yeast epimerase has an N-terminal domain (residues
1–377) that shows significant similarity withEscherichia coli
and human UDPgalactose 4-epimerase, and a C-terminal
domain (residues 378–699), which shows extensive identity
to either the bacterial or human aldose 1-epimerase (muta-
rotase). The S. cerevisiae epimerase was purified to >95%
homogeneity by sequential chromatography on DEAE-
Sephacel and Resource-Q columns. Purified epimerase
preparations showed mutarotase activity and could convert
either a-D-glucose or a-D-galactose to their b-anomers.
Induction of cells with galactose led to simultaneous
enhancement of both epimerase and mutarotase activities.
Size exclusion chromatography experiments confirmed that
the mutarotase activity is an intrinsic property of the yeast
epimerase and not due to a copurifying endogenous muta-
rotase. When the purified protein was treated with 5¢-UMP
and L-arabinose, epimerase activity was completely lost but
the mutarotase activity remained unaffected. These results
demonstrate that the S. cerevisiae UDPgalactose 4-epi-
merase is a bifunctional enzyme with aldose 1-epimerase
activity. The active sites for these two enzymatic activities are
located in different regions of the epimerase holoenzyme.
Keywords: aldose 1-epimerase; bifunctional enzyme; reduc-
tive inhibition; Saccharomyces cerevisiae; UDPgalactose
4-epimerase.
UDPgalactose 4-epimerase (henceforth called epimerase) is
an essential enzymeof the galactosemetabolic pathway.This
enzyme catalyses a freely reversible reaction between UDP-
galactose and UDPglucose, and is responsible for both
catabolism and anabolism of galactose in all cell types
studied so far. The reaction mechanism involves abstraction
of the 4¢-hydroxyl hydrogen by an enzymatic base and
hydride transfer from C4 of the sugar to the nicotinamide
ring of NAD+. Subsequent formation of UDP 4-keto sugar
andNADHas transient intermediate on the enzyme surface,
followed by stereospecific return of hydride fromNADH to
the opposite face of the keto sugar results in epimerization of
the substrate and regeneration of NAD+ [1].
Epimerase has been purified and characterized from
Escherichia coli to humans. Both the E. coli [2] and human
epimerase [3] are homodimeric proteins, each with a
molecular mass of approximately 80-kDa, and contains
one tightly bound NAD+ as a cofactor in each subunit.
Most of the mechanistic and crystallographic studies have
been carried out with the E. coli and human protein [1].
Epimerase has also been purified and analyzed from the
yeast Kluyveromyces fragilis [4–6] and Saccharomyces cere-
visiae [7]. Both the yeast proteins are homodimers with an
apparent molecular mass of 156-kDa and contain enzyme
bound NAD+. Why do yeast epimerases have twice the
molecular mass of either the E. coli or human protein? A
BLAST search [8] using the S. cerevisiae epimerase as the
query sequence revealed that the 699 amino acid protein
has two domains. The N-terminal domain (residues 1–377)
showed a high degree of sequence identity with either
the E. coli or human epimerase. The C-terminal domain
(residues 378–699) showed significant identity to bacterial or
human aldose 1-epimerase sequence.
Aldose 1-epimerase (henceforth called mutarotase) cata-
lyzes the equilibration of a- and b-anomers of aldoses [9,10].
Mutarotase plays a key role in linking lactose and galactose
metabolism. Hydrolysis of lactose by b-galactosidase gen-
erates a-D-glucose and b-D-galactose. While a-D-glucose is
phosphorylated by glucokinase for glycolysis, b-D-galactose
needs to be transformed to a-D-galactose before being
phosphorylated by galactokinase. Mutarotase catalyzes the
interconversion of b-D-galactose to a-D-galactose, which
is then converted to the metabolically useful glucose
1-phosphate by the concerted action of three enzymes of
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the Leloir pathway: galactokinase, galactose 1-phosphate
uridylyltransferase, and UDPgalactose 4-epimerase.
A multiple-sequence alignment of the C-terminal domain
of the S. cerevisiae epimerase (residues 378–699) with the
complete sequence of E. coli [11], Lactococcus lactis [12],
and human [13] mutarotase is shown in Fig. 1. These
mutarotases show 24–31% identity and 45–48% similarity
with the C-terminal half of the yeast protein, indicating that
the yeast epimerase might have additional mutarotase
activity. To resolve this question, we cloned, expressed
and purified S. cerevisiae epimerase to homogeneity, and
assayed for mutarotase activity. We report that the purified
yeast protein does indeed have both epimerase and muta-
rotase activities. We also report that these two enzymatic
activities are located in different regions of the protein.
Materials and methods
Materials
All biochemicals unless otherwise stated were purchased
from Sigma. Restriction enzymes and Taq DNA
polymerase were from Invitrogen. Amicon centrifugal filter
units were from Millipore while DEAE-Sephacel and
Sephacryl S-200 HR was purchased from Amersham
Biosciences.
Fig. 1. Sequence alignment of the C-terminal domain (residues 378–699) of the S. cerevisiae epimerase with the complete amino acid sequence ofHomo
sapiens, E. coli, and L. lactis mutarotase. The GenBank Accession numbers are S. cerevisiae (NP_009575), H. sapiens (NP_620156), E. coli
(P40681), and L. lactis (CAB44215). Multiple alignments were carried out using the BCM Search launcher (http://searchlauncher.bcm.tmc.edu/
multi-align/multi-align.html). Amino acids marked with black or gray boxes indicate sequence identity or similarity, respectively. The dashes
indicate the gaps introduced to maximize sequence alignment.
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Strains and growth conditions
E. coli strain DH-5a (F–F80 dlacZDM15 D(lacZYA-argF)
U169 recA1 endA1 hsdR17(rk
–, mk
+) phoA supE44 k– thi-1
gyrA96 relA1) (Invitrogen) was used for cloning experi-
ments. E. coli strains were grown in LB medium [14]
supplemented with 100 lgÆmL)1 ampicillin. The diploid
S. cerevisiae strain (wild-type) used in the purification
of endogenous epimerase was derived from S. cerevisiae
strains 8534-10A (MATa leu2-3, 112 ura3-52 his4D34) and
6460-8D (MATa met3) [15]. Yeast strain PJB5 with a
disrupted gal10 locus (MATa ade2-101 ile ura3-52 leu2-3112
trp1-HIII his3D-1 MEL1 gal10::LEU2 ) [16] was used for
expression of the recombinant protein. S. cerevisiae strains
were grown at 30 C in either YEP medium (1% bacto-
yeast extract, 2% bacto-peptone, and either 2% glucose or
galactose; w/v) or synthetic minimal medium containing
either 2% glucose or galactose [17].
Cloning and expression
A 2.1-kb fragment containing the complete GAL10 gene
along with 54 bp of its upstream sequence was amplified by
PCR from S. cerevisiae genomic DNA using a sense primer
5¢-TCAGGATCCACTTCTTTGCGTCCATCC-3¢ that
introduced a BamHI restriction site and an antisense primer
5¢-CCACTGCAGTCAGGAAAATCTGTAGAC-3¢ that
introduced a PstI restriction site. The PCR fragment was
ligated with pBluescriptIIKS+ vector (Stratagene) creating
pBluescript-GAL10. The absence of any mutation was
confirmed by complete sequencing of the PCR product
using the ABI Prism-377 DNA sequencer (Applied Biosys-
tems). pBluescript-GAL10 was digested with BamHI and
PstI and the gel-purified DNA fragment containing the
coding region and termination signal of GAL10 was ligated
into BamHI-PstI digested S. cerevisiae centromeric expres-
sion vector pUS234, creating pUSGAL10. pUS234 was
generated (by Uttam Surana, Institute of Molecular and
Cell Biology, Singapore) after cloning an EcoR1/BamH1
fragment containing GAL1-10 promoter into S. cerevisiae
shuttle vector Ycplac33 [18]. The plasmid pUSGAL10 was
introduced into gal10-deficient strain PJB5 (henceforth
called transformed PJB5) by following the method of Gietz
et al. [19]. To test for complementation of the gal10mutant,
transformed PJB5 cells were grown on synthetic minimal
medium containing 2% galactose.
Purification of epimerase
Both wild-type and transformed S. cerevisiae cells were
grown and harvested as described by Fukasawa et al. [7]. A
modification of the previously reported purification proce-
dure [7] was used. Unless otherwise mentioned, all steps in
the protein purification protocol were performed at 4 C.
Frozen cells (15–20 g) were thawed quickly and suspended
in 3 mL per gram of wet cells of buffer A (20 mM Tris/HCl,
pH 7.4 containing 1 mM EDTA, 1 mM phenylmethane-
sulfonyl fluoride, and 5 mM DL-dithiothreitol). The cells
were lysed by two passages through a French pressure cell at
20 000 p.s.i. Unbroken cells and cell debris were removed
after centrifugation at 12 000 g for 30 min and the super-
natant was retained (crude extract). The crude extract was
treated with 35–55% ammonium sulfate and the precipita-
ted protein was dissolved in buffer B (20 mM Tris/HCl,
pH 7.4 containing 1 mM EDTA and 5 mM dithiothreitol).
The protein was desalted and concentrated using Amicon
Ultra-15 (50-kDa cut-off) centrifugal filter. The concentra-
ted protein was applied at a flow rate of 0.3 mLÆmin)1 to a
DEAE-Sephacel column (20 · 2 cm) equilibrated with
buffer B. The column was washed with 150 mL of buffer
B and the protein eluted from the column with a 400 mL
linear gradient of 20 mM to 500 mM Tris/HCl, pH 7.4 at a
flow rate of 0.2 mLÆmin)1. Fractions of 3 mLwere collected
and analyzed by SDS/PAGE [20] as well as assayed for
epimerase activity. The most active fractions were pooled,
desalted and concentrated using Amicon Ultra-15 (50-kDa
cutoff) centrifugal filter. The concentrated protein was
applied at a flow rate of 1 mLÆmin)1 on a 1 mLResource-Q
column (Amersham Biosciences) equilibrated with buffer B.
The column was washed with 10 mL of buffer B and the
protein eluted from the column by a step gradient of 0–1 M
NaCl in buffer B. Fractions containing the epimerase
protein were quickly frozen in a dry ice/ethanol bath and
stored at )70 C in aliquots. Epimerase purified from wild-
type cells will be referred to as wild-type protein while that
purified from transformed PJB5 cells will be described as
recombinant protein. Protein concentration in crude prep-
arations were measured by the method of Lowry et al. [21],
while the concentration of epimerase in purified prepara-
tions was determined by the absorption at 280 nm using a
molar extinction coefficient of 85 260 [22].
Epimerase assay
Epimerase activity was assayed using an NADH-coupled
assay developed by Wilson and Hogness [23]. In this case,
UDP-glucose, the product of epimerization, is immedi-
ately converted to UDP-glucuronic acid by coupling the
reaction with UDP-glucose dehydrogenase and NAD+.
The assay mixture consisted of 0.1 M glycylglycine buffer,
pH 8.8, 0.25 mM NAD+, 0.16 units of UDP-glucose
dehydrogenase, and 0.5 lg of epimerase. The reaction
was started by the addition of 0.35 mM UDP-galactose,
and the increase in absorbance due to formation of
NADH was measured at 340 nm over a linear range of
2–5 min.
Mutarotase assay
Mutarotase activity was measured with a DIP-360 polari-
meter (Jasco). This assay is based upon the change in optical
rotation of the substrate (a-D-glucose or a-D-galactose)
during an enzyme catalyzed mutarotation reaction [10].
a-D-Glucose (65 mM) was dissolved in 5 mM Tris HCl,
pH 7.4 buffer containing 1 mM EDTA, immediately before
addition of the enzyme. The solutionwas rapidly introduced
into the polarimeter tube, and readings for optical rotation
were taken at 1-min intervals for 6 min. The rate of the
nonenzymatic turnover was subtracted from the initial rate
of the enzymatic reaction.
Mutarotase activity was also assayed using the NAD+
and b-D-glucose dehydrogenase coupled assay [11,24]. In
this method, the conversion of a-D-glucose to b-D-glucose
is coupled to oxidation of b-D-glucose by b-D-glucose
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dehydrogenase and reduction of NAD+. The assay mixture
consisted of 0.1 M Tris/HCl buffer, pH 7.2, 3 mM NAD+,
10 units of b-D-glucose dehydrogenase, and 5 lg of
epimerase. The reaction was initiated by the addition of
5 mM freshly dissolved a-D-glucose, and the increase in
absorbance was measured at 340 nm over a linear range.
Sephacryl S-200 chromatography
The wild-type strain was grown in YEPmedium containing
either 2% (w/v) glucose or galactose. The gal10 strain was
grown in 3% (v/v) glycerol containing 10 mM a-D-fucose.
Cells (1 g) were suspended and lysed as described above.
The crude extract was treated with 0–70% ammonium
sulfate and the precipitated protein was dissolved in 2 mLof
buffer B. Approximately 20–30 mg of the protein was
loaded on a Sephacryl S-200 column (20 · 2 cm) pre-
equilibrated with buffer B. Elution was carried out with
buffer B at a flow rate of 0.15 mLÆmin)1. Fractions of 2 mL
were collected and analyzed for both epimerase and
mutarotase activities as well as for their protein content.
Reductive inhibition
Epimerase (10 lg) was incubated at room temperature
with 2 mM uridine 5¢-monophosphate (5¢-UMP) and
10 mM L-arabinose in 10 mM potassium phosphate buffer,
pH 8.0. Aliquots of the reaction mixture were removed at
intervals and passed through a spin column [25] to remove
the nucleotide and free sugar. The eluate was then assayed
for both epimerase and mutarotase activity.
Results
Purification of UDPgalactose 4-epimerase
The purification procedure for UDPgalactose 4-epimerase
from S. cerevisiae is described in theMaterials and methods
section and also summarized in Table 1. Either the wild-
type or the recombinant epimerase was purified from
S. cerevisiae cytosol using sequential chromatography on
DEAE Sephacel and Resource-Q columns. Figure 2 shows
a sharp, single protein peak following elution from the
Resource-Q column. The purified epimerase preparation
was judged to be >95% homogeneous by Coomassie blue
staining of samples separated by SDS/PAGE (Fig. 2, inset).
The specific activity of the purified epimerase preparation
was in excess of 25 unitsÆmg)1 of protein. This method is
faster and more convenient than the purification procedure
described by Fukasawa et al. [7].
Aldose-1-epimerase activity of UDPgalactose
4-epimerase
Purified epimerase preparations were analyzed for mut-
arotase activity by polarimetric method. The change in
optical rotation of the substrate (glucose or galactose)
was measured as the a-anomer was converted to the
equilibrium mixture of isomers. Although glucose under-
goes spontaneous mutarotation with a first-order rate
constant of 0.032 min)1 at 25 C [10], the addition of the
Table 1. Purification of UDPgalactose 4-epimerase from S. cerevisiae.
Steps
Total
protein (mg)
Total activity
(units)
Specific activity
(unitsÆmg)1) Ratio of
Epimerase :
Mutarotase
Activity
Fold purification
Epimerase Mutarotase Epimerase Mutarotase Epimerase Mutarotase
Crude extract 2460 718 8610 0.3 3.5 1 : 12 1 1
Ammonium sulfate
fractionation
760 671 7100 0.9 9 1 : 10 3 3
DEAE-Sephacel
chromatography
44 557 5200 13 118 1 : 9 43 34
Resource-Q
chromatography
9 225 2026 25 225 1 : 9 83 64
Fig. 2. Purification of S. cerevisiae epimerase. Elution profile of the
protein from a Resource Q column. Arrow indicates initiation of ionic
gradient. Inset: SDS/PAGE analysis at each step of purification.
Lane 1, crude extract (cytosol); lane 2, ammonium sulfate precipitated
and Amicon ultramembrane filtered fraction; lane 3, pooled fraction
from DEAE-Sephacel column; lane 4, pooled fraction from Resource-
Q column.
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protein resulted in an even greater increase in optical
rotation. The first-order rate constant for the catalyzed
mutarotation reaction was acquired from the slope of the
straight line plot obtained by plotting ln(ao – ae)/(at –
ae) ¼ kt, where ao, at, and ae are the observed angular
rotations at time zero, t and equilibrium, respectively,
and k is the calculated rate constant [10]. A linear
increase in the first order rate constant was obtained with
increasing quantities of the purified enzyme (Fig. 3). A
similar kinetics was observed when a-D-galactose was
used as the substrate. Additionally, a coupled assay
method using b-D-glucose dehydrogenase as the coupling
enzyme was also employed to confirm the presence of
mutarotase activity in epimerase. Using a-D-glucose as a
substrate, the enzymatic assay was linear over the first
five minutes, and an increase in enzyme concentration
proportionately increased the rate of reaction (data not
shown). Mutarotase activity was also assayed for glucose
or galactose induced cell lysate. The rate of conversion of
a-D-glucose to b-D-glucose in induced and uninduced cell
lysates are 3.5 lmolÆmin)1 and 2.2 lmolÆmin)1Æmg)1 of
protein, respectively. These rates are much higher than
the observed spontaneous rotation rate of 0.1 lmolÆmin)1.
To determine that the mutarotase activity is an intrinsic
property ofS. cerevisiae epimerase, the ratio of epimerase to
mutarotase activity was monitored during each stage of
purification (Table 1). Crude cytosolic extract showed an
epimerase: mutarotase activity of 1 : 12. After an ammo-
nium sulfate precipitation and Amicon centrifugal filtration
step the ratio changed to 1 : 10. The ratio of epimerase
to mutarotase activity attained a constant value of
1 : 9 following DEAE–Sephacel chromatography. This
suggested that the ion-exchange column might be sep-
arating a copurifying constitutive mutarotase from
epimerase.
To examine the possibility that the mutarotase activity
of epimerase was not due to a copurifying constitutive
mutarotase, a gel filtration chromatography experiment
was performed. The presence of a constitutive mutarotase
in S. cerevisiae has been reported earlier by Sammler et al.
[26]. Moreover, a BLAST search showed two S. cerevisiae
open reading frames (ORFs) YHR210c and YNR071c,
with putative aldose 1-epimerase activity. These ORFs
encode for proteins, each with a predicted molecular mass
of 38-kDa, and exhibit 99% identity with the human
aldose 1-epimerase [13]. Both the E. coli and human
aldose 1-epimerase have been shown to exist as a
monomer in solution [13,27]. However, the crystal struc-
ture of L. lactis enzyme indicates the protein to be a
dimer [28]. On the other hand, the yeast epimerase is
present as a 156-kDa dimeric species [7]. Therefore, size
exclusion chromatography experiments were performed to
separate the yeast epimerase from any copurifying consti-
tutive mutarotase species.
Cells were grown in YEP medium in presence of 2%
glucose, harvested and lysed as described in Materials and
methods. The cytosolic proteins were collected by satur-
ated ammonium sulfate (0–70%) precipitation, dissolved
in minimum volume of buffer and loaded on a Sephacryl
S-200 column. The fractions were monitored for epi-
merase and mutarotase activities as well as for protein
content. Figure 4A shows the elution profile of epimerase
that is distinctly separated from a constitutively expressed
mutarotase. The fractions containing epimerase activity
also showed mutarotase activity. If S. cerevisiae epimerase
were a truly bifunctional enzyme, then induction with
galactose should induce both epimerase and mutarotase
activity. When a similar experiment was performed after
inducing the cells with galactose, there was 3.5-fold
increase in epimerase activity (Fig. 4B) while the consti-
tutive mutarotase activity remained the same. More
importantly, with the increase in epimerase activity, the
coeluting mutarotase activity was also induced nearly
3.5-fold. This indicated that yeast epimerase also has
additional mutarotase activity. This conclusion was
further confirmed when gal10 strain (PJB5), totally
lacking epimerase activity was used as a control. PJB5
cells were grown in 3% glycerol and 10 mM a-D-fucose.
a-D-Fucose is an inducer for gal operon that acts by
inactivating the gal repressor [11]. In this case, apart from
the constitutive mutarotase, no other mutarotase activity
was detected (Fig. 4C). Absence of epimerase activity in
the gal10 strain also led to simultaneous lack of epimerase
associated mutarotase activity. The gal10 strain (PJB5)
cannot grow on media containing galactose as the sole
carbon source due to lack of epimerase activity. This
observed sensitivity could be complemented by expression
of GAL10 from a plasmid. When transformed cells were
grown in presence of galactose, lysed, and similarly
fractionated as the wild-type cells, both epimerase and
mutarotase activities coeluted in the same fractions (data
not shown). These set of experiments clearly indicate the
presence of both epimerase and mutarotase activities in
the same protein.
Fig. 3. Polarimetric assay of mutarotase activity of S. cerevisiae
epimerase. First-order mutarotation reactions for a-D-glucose alone
and in the presence of increasing amount of epimerase. d, spon-
taneous mutarotation (only a-D-glucose); s, 1 lg epimerase; n,
2 lg epimerase. Inset: Plot of rate constant vs. micrograms of
epimerase.
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Distinct active site for aldose-1-epimerase
in UDPgalactose 4-epimerase
The participation of NAD+ as an initial reductant is
essential for the epimerization process [1]. The question
arises whetherNAD+ is also critical formutarotase activity.
Bhaduri et al. [29] had earlier shown that upon incubation
of yeast epimerase with 5¢-UMP and a free sugar such as
D-glucose or L-arabinose, the NAD+ bound form of the
enzyme is slowly but irreversibly reduced to NADH. The
formation of NADH on the enzyme surface is accompanied
by progressive enhancement of fluorescence along with a
corresponding decrease in enzymatic activity and the
process was termed as reductive inhibition. Upon incuba-
tion of purified epimerase with 5¢-UMP and L-arabinose,
the epimerase activity was progressively lost, while the
mutarotase activity of the enzyme remained completely
unaffected (Fig. 5). This clearly indicated that NAD+ is not
essential for mutarotase activity and mutarotation did not
proceed through an oxidation–reduction mechanism.
Therefore, epimerase and mutarotase activities are located
in different regions of the epimerase holoenzyme.
Discussion
The identification of mutarotase activity in S. cerevisiae
epimerase is supported by several lines of evidence. First, the
protein was purified to >95% homogeneity and shown to
possess mutarotase activity by two independent assay
methods. Either a-D-glucose or a-D-galactose could serve
as the substrate. Second, size exclusion chromatography
experiments showed that epimerase and mutarotase acti-
vities coeluted in the same fractions, and were conveniently
separated from constitutive mutarotases. Finally, induction
of cells with galactose led to a simultaneous enhancement of
epimerase and mutarotase activity, whereas both activities
were absent in the gal10 strain. Reductive inhibition
experiments clearly showed that the catalytic centers of
epimerase and mutarotase activity are independent of each
other.
It has been shown that E. colimutarotase do not require
either metal ions or cofactors for activity [27]. A possible
catalytic mechanism was first suggested by Hucho and
Wallenfels [9], which involved the abstraction of a proton
from the C1 hydroxyl group of the sugar by an active base
and donation of a proton to the C5 ring oxygen by an active
site acid, thereby leading to ring opening. Subsequent
rotation of 180 about the C1–C2 bond followed by
abstraction of the proton on the C5 oxygen and donation
of a proton back to the C1 oxygen generated the product.
The crystal structure of L. lactis mutarotase indicates that
Glu304 serves as the active site base to abstract the C1
hydroxyl hydrogen and His170 functions as the active site
acid to protonate the C5 ring oxygen [1,30]. A similar
mechanism has been proposed for the E. coli mutarotase
where His175 has been suggested to be involved in catalysis
[27]. Also, site-directed mutagenesis and kinetic experiments
implicates His176 and Glu307 as active site acid and base,
respectively, for the human mutarotase [13]. A multiple
sequence alignment of yeast epimerase withE. coli,L. lactis,
and human mutarotase (Fig. 1) indicates that His537 and
Glu665 of the S. cerevisiae epimerase are most likely to play
a role in acid-base catalysis. Site-directed mutagenesis
experiments are currently in progress to investigate the role
of these residues in epimerase-associatedmutarotaseactivity.
A BLAST analysis shows that UDPgalactose 4-epi-
merase from Kluyveromyces lactis (687 amino acids),
Pachysolen tannophilus (689 amino acids), and Schizosac-
charomyces pombe (713 amino acids) exhibit 52–56%
Fig. 5. Effectofreductive inhibitiononepimeraseandmutarotaseactivity.
Epimerase (10 lg) was incubated with 2 mM 5¢-UMP and 10 mM
L-arabinose at room temperature. Aliquots were taken at intervals and
assayed for both epimerase (d) andmutarotase (s) activity.
Fig. 4. Separation of epimerase from constitutive mutarotase in a
Sephacryl S-200 column. Cells were grown, harvested and lysed as
described in Materials and methods. Fractions were monitored for
both epimerase (d) and mutarotase (n) activity as well as for their
protein content (s). Wild-type strain grown in 2% glucose (A) or 2%
galactose (B) and gal10 strain grown in 3% glycerol (C).
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identity and 68–72% similarity with S. cerevisiae epimerase.
We would therefore hypothesize that K. lactis, P. tannophi-
lus, and S. pombe epimerase to have an intrinsic mutarotase
activity. However, not all fungal epimerases are likely to
havemutarotase activity. Seiboth et al. [31] have shown that
theGAL10 gene of the filamentous fungiHypocrea jecorina,
codes for a 370-amino acid protein that does not contain
the C-terminal mutarotase domain. Similarly, Neurospora
crassa Gal10p has 375-amino acids in its primary structure
and lacks the C-terminal extension of the S. cerevisiae
epimerase. The evolutionary history of the fusion of
epimerase and mutarotase activity in the yeast enzyme
remains entirely speculative at this moment and further
work is needed before we begin to appreciate its biological
significance.
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